This industry leader, which completed its first-ever stock split, has rallied 271% over the trailing-three-year period.

Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development ...

Public Limited Company (NASDAQ:SMX; SMXWW) (the “Company”), today announced that the reverse stock split of the Company’s ...

NEWPORT BEACH, CA / ACCESS Newswire / June 12, 2025 / Amaze Holdings, Inc. (NYSE American:AMZE) (“Amaze” or the “Company”),a ...

CERo Therapeutics (NASDAQ:CERO) will implement a 1-for-20 reverse stock split on June 13, 2025. The split reduces outstanding ...

The Company's stockholders approved a reverse stock split at a ratio of between 1-for-10 and 1-for-20 at the Company's Annual Meeting of Stockholders held on June 4, 2025. The Company's Board of ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, ...

These are the upcoming stock splits for the week of June 16 to June 20, based on TipRanks’ Stock Splits Calendar. A stock ...

FibroGen, Inc. (NASDAQ: FGEN) today announced that it will implement a 1-for-25 reverse stock split of its issued and ...

A high-octane company outside of the tech sector will be completing its first-ever forward stock split in the coming days.

RAPT Therapeutics, Inc. (Nasdaq: RAPT) (the "Company"), a clinical-stage immunology-based biopharmaceutical company focused on discovering ...

Tilray Brands has “paused” plans to reduce the number of market-traded shares as the company assesses its options.